48
Participants
Start Date
February 28, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2026
Lorundrostat
Lorundrostat tablet.
Placebo
Lorundrostat matching placebo tablet.
Velocity Clinical Research, Rockville, Rockville
Centennial Medical Group, Columbia
Research Carolina Elite, Denver
NeuroTrials Research Inc, Atlanta
Centricity Research Rincon Pulmonology, Rincon
Arrow Clinical Trials, Daytona Beach
CNS Healthcare - Orlando (Clinical Neuroscience Solutions), Orlando
PharmaDev Clinical Research Institute, LLC, Miami
Nouvelle Clinical Research, Cutler Bay
The University of Alabama, Tuscaloosa
CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis), Memphis
CTI Clinical Research Center, Cincinnati
Revive Research Institute, Inc, Southfield
Henry Ford Health System/Henry Ford Medical Center - Columbus, Novi
Chicago Research Center Inc, Chicago
Healthcare Research Network, Hazelwood
Clayton Sleep Institute, St Louis
Preferred Research Partners Inc., Little Rock
Huntsville Research Institute LLC, Huntsville
Sleep Therapy Research Center, San Antonio
Chandler Clinical Trials, Chandler
The Neurology Center of Southern California - Profound Research, LLC, Carlsbad
Probe Clinical Research Corporation, Riverside
Orange County Research Institute, Anaheim
Northwest Research Center, Portland
University of Washington, Seattle
Patient First MD, Middletown
Lead Sponsor
Mineralys Therapeutics Inc.
INDUSTRY